The Apoptosis Inhibitor ARC Alleviates the ER Stress Response to Promote β-Cell Survival
- Wendy M. McKimpson1,2,3,
- Jeremy Weinberger1,2,3,
- Lech Czerski1,2,3,
- Min Zheng1,2,3,
- Michael T. Crow4,
- Jeffrey E. Pessin1,5,6,
- Streamson C. Chua Jr.1,6,7 and
- Richard N. Kitsis1,2,3,6,8⇓
- 1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
- 2Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York
- 3Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York
- 4Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
- 5Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York
- 6Diabetes Research Institute, Albert Einstein College of Medicine, Bronx, New York
- 7Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York
- 8Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York
- Corresponding author: Richard N. Kitsis, .
Type 2 diabetes involves insulin resistance and β-cell failure leading to inadequate insulin secretion. An important component of β-cell failure is cell loss by apoptosis. Apoptosis repressor with caspase recruitment domain (ARC) is an inhibitor of apoptosis that is expressed in cardiac and skeletal myocytes and neurons. ARC possesses the unusual property of antagonizing both the extrinsic (death receptor) and intrinsic (mitochondria/endoplasmic reticulum [ER]) cell death pathways. Here we report that ARC protein is abundant in cells of the endocrine pancreas, including >99.5% of mouse and 73% of human β-cells. Using genetic gain- and loss-of-function approaches, our data demonstrate that ARC inhibits β-cell apoptosis elicited by multiple inducers of cell death, including ER stressors tunicamycin, thapsigargin, and physiological concentrations of palmitate. Unexpectedly, ARC diminishes the ER stress response, acting distal to protein kinase RNA-like ER kinase (PERK) and inositol-requiring protein 1α, to suppress C/EBP homologous protein (CHOP) induction. Depletion of ARC in isolated islets augments palmitate-induced apoptosis, which is dramatically rescued by deletion of CHOP. These data demonstrate that ARC is a previously unrecognized inhibitor of apoptosis in β-cells and that its protective effects are mediated through suppression of the ER stress response pathway.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db12-0504/-/DC1.
- Received April 19, 2012.
- Accepted July 30, 2012.
- © 2013 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.